OXA and 5-Fu markedly activated caspase-3/PARP apoptotic signaling, which could be inhibited by simultaneous treatment with IL-6 (Fig. 5b and Supplementary Fig. 6b), indicating that IL-6 promotes chemotherapy resistance in CRC cells. This evidence concerns the gene IL6 and colorectal carcinoma.